Free radical scavenger edaravone suppresses X-ray-induced apoptosis through p53 inhibition in MOLT-4 cells

Journal of Radiation Research

Volumn 48, Issue 6, 2007, Pages 495-503

  Sasano, Nakashi ^a,b   Enomoto, Atsushi ^b   Hosoi, Yoshio ^b   Katsumura, Yosuke ^c   Matsumoto, Yoshihisa ^b   Shiraishi, Kenshiro ^a   Miyagawa, Kiyoshi ^b   Igaki, Hiroshi ^a   Nakagawa, Keiichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Edaravone; Free radical scavenger; MOLT 4 cells; Radioprotective effect; X ray induced apoptosis

Indexed keywords

CELL DEATH; FREE RADICALS;

CEREBRAL INFARCTION; CLINICAL DRUGS; DYE EXCLUSION; EDARAVONE; FREE-RADICAL SCAVENGERS; INDUCED APOPTOSIS; MOLT-4 CELL; RADIOPROTECTIVE EFFECT; X-IRRADIATION; X-RAY-INDUCED APOPTOSIS;

IRRADIATION;

EID: 36749011255     PISSN: 04493060     EISSN: 13499157     Source Type: Journal    
DOI: 10.1269/jrr.07061     Document Type: Article

References (58)

1. Bernhard, W. A. and Close, D. M. (2004) Charged Particle and Photon Interaction with Matter. Eds. Mozunder, A. and Hatano, Y., pp. 431-470, Marcel Dekker Inc.
2. von Sontag, C. (1987) The Chemical Basis of Radiation Biology. Tayler and Fransis, New York.
3. Radford, I. R. and Murphy, T. K. (1994) Radiation response of mouse lymphoid and myeloid cell lines: III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage. Int. J. Radiat. Biol. 65: 229-239.
4. Kerr, J. F. R., Wyllie, A. H. and Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide range implications in tissue kinetics. Br. J. Cancer 26: 239-257.
5. Yamada, T. and Ohyama, H. (1988) Radiation-induced interphase death of rat thymocyte is internally programmed (apoptosis). Int. J. Radiat. Biol. 53: 65-75.
6. Hosokawa, Y., Tanaka, L., Kaneko, M., Sakakura, Y., Tsuruga, E., Irie, K. and Yajima, T. (2002) Apoptosis induced by generated OH radicals inside cells after irradiation. Arch. Histol. Cytol 65: 301-305.
7. Watanabe, T., Yuki, S., Egawa, M. and Nishi, H. (1994) Protective effects of MCI-186 on cerebral ischemia: Possible involvement of free radical scavenging and antioxidant actions. J. Pharmacol. Exp. Ther. 268: 1597-1603.
8. Yamamoto, T., Yuki, S., Watanabe, T., Mitsuka, M., Saito, K. and Kogure, K. (1997) Delayed neuronal death prevented by inhibition of hydroxyl radical formation in a transient cerebral ischemia. Brain Res. 762: 240-242.
9. Mizuno, A., Uemura, K. and Nakashima, M. (1998) Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusion. Gen. Parmacol. 30: 575-578.
10. Abe, K., Yuki, S. and Kogure, K. (1988) Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19: 280-285.
11. Nishi, H., Watanabe, T., Sakurai, H., Yuki, S. and Ishibashi, A. (1989) Effect of MCI-186 on brain edema in rats. Stroke 20: 1236-1240.
12. Watanabe, T. and Egawa, M. (1994) Effects of an antistroke agent MCI-186 on cerebral arachidonate cascade. J. Pharmacol. Exp. Ther. 271: 1624-1629.
13. Kawai, H., Nakai, H., Suga, M., Yuki, S., Watanabe, T. and Saito, K. -I. (1997) Effects of a novel free radical scavenger, MCI-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J. Pharmacol. Exp. Ther. 281: 921-927.
14. Watanabe, K., Watanabe, K., Kuwahara, T. and Yamamoto, Y. (1997) Free radical-induced oxidation products of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). J. Jpn. Oil Chem. Soc. 46: 797-801.
15. Amemiya, S., Kamiya, Y., Nito, C., Inaba, Y., Kato, K., Ueda, M., Shimazaki, K. and Katayama, Y. (2005) Anti-apoptotic and neuroprotective effects of edaravone following focal ischemia in rats. Eur. J. Pharmacol. 516: 125-130.
16. Shichinohe, Y., Kuroda, S., Yasuda, H., Ishikawa, T., Iwai, M., Horiuchi, M. and Iwasaki, Y. (2004) Neuroprotective effects of the free radical scavenger Edaravone (MCI-186) in mice permanent focal brain ischemia. Brain Res. 1029: 200-206.
17. Nito, C., Kamiya, T., Amemiya, S., Kato, K. and Katayama, Y. (2003) The neuroprotective effect of a free radical scavenger and mild hypothermia following transient focal ischemia in rats. Acta. Neurochir. Suppl. 86: 199-203.
18. Ikeda, T., Xia, XY., Kaneko, M., Sameshima, H. and Ikenoue, T. (2002) Effect of the free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), on hypoxia-ischemiainduced brain injury in neonatal rats. Neurosci. Lett. 329: 33-36.
19. Noor, JI., Ikeda, T., Ueda, Y. and Ikenoue, T. (2005) A free radical scavenger, edaravone, inhibits lipid peroxidation and the production of nitric oxide in hypoxic-ischemic brain damage of neonatal rats. Am. J. Obstet. Gynecol. 193: 1703-1708.
20. Nakashima, N., Niwa, M., Iwai, T. and Uematsu, T. (1999) Involvement of free radicals in cerebral vascular reperfusion injury evaluated in a transient focal cerebral ischemia model of rat. Free Radic. Biol. Med. 26: 722-729.
21. Watanabe, T., Morita, I., Nishi, H. and Murota, S. (1988) Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot. Essent. Fatty Acids 33: 81-87.
22. Yamaguchi, T., Ida, T., Kobayashi, T., Hiraga, M., Oishi, K., Uchida, M. K. and Echizen, H. (2004) Alterations of antiproliferative effects of serum obtained from patients with acute cerebral infarction treated with a radical scavenger, edaravone, with or without amlodipine using an in vitro cultured basilar artery smooth muscle cells. Yakugaku Zasshi 124: 25-29.
23. Edaravone Acute Infarction Study Group. (2003) Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis. 15: 222-229.
24. Toyoda, K., Fujii, K., Kamouchi, M., Nakane, H., Arihiro, S., Okada, Y., Ibayashi, S. and Iida, M. (2004) Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion. J. Neurol. Sci. 221: 11-17.
25. Watanabe, T., Tanaka, M., Watanabe, K., Takamatsu, Y. and Tobe, A. (2004) Research and development of the free radical scavenger edaravone as a neuroprotectant. Yakugaku Zasshi. 124: 99-111.
26. Mishina, M., Komaba, Y., Kobayashi, S., Tanaka, N., Kominami, S., Fukuchi, Y., Mizunari, T., Hamamoto, M., Teramoto, A. and Katayama, Y. (2005) Efficacy of edaravone, a free radical scavenger, for the treatment of acute lacunar infarction. Neurol. Med. Chir. (Tokyo) 45: 344-348. discussion 348.
27. Watanabe, K., Watanabe, K. and Hayase, T. (1997) Radical scavenging mechanism of MCI-186. Jpn. Pharmacol. Ther. 25: S1699-S1707.
28. Watanabe, K., Watanabe, K., Kuwahara, T. and Yamamoto, Y. (1997) Free radical-induced oxidation products of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). J. Jpn. Oil. Chem. Soc. 46: 797-801.
29. Abe, S., Kirima, K., Tsuchiya, K., Okamoto, M., Hasegawa, T., Houchi, H., Yoshizumi, M. and Tamaki, T. (2004) The reaction rate of edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186)) with hydroxyl radical. Chem. Pharm. Bull. 52: 186-191.
30. Anzai, K., Furuse, M., Yoshida, A., Matsuyama, A., Moritake, T., Tsuboi, K. and Ikota, N. (2003) In vivo radioprotection of mice by 3-methyl-1-phenyl-2-pyrazolin-5-one (Edaravone; Radicut), a clinical drug. J. Radiat. Res. 45: 319-323.
31. Peng, R., Wang, D., Wang, B., Xia, G., Li, Y., Xiong, C., Gao, Y., Yang, H. and Cui, Y. (1999) Apoptosis of hemopoietic cells in irradiated mouse bone marrow. J. Environ. Pathol. Toxicol. Oncol. 18: 305-308.
32. Nakano, H., Kohara, M. and Shinohara, K. (2001) Evaluation of the relative contribution of p53-mediated pathway in X-ray-induced apoptosis in human leukemic MOLT-4 cells by transfection with a mutant p53 gene at different expression levels. Cell Tissue Res. 306: 101-106.
33. Morita, A., Suzuki, N., Matsumoto, Y., Hirano, K., Enomoto, A., Zhu, J. and Sakai, K. (2000) p41 as a possible marker for cell death is generated by caspase cleavage of p42/SET β in irradiated MOLT-4 cells. Biochem. Biophys. Res. Commun. 278: 627-632.
34. Enomoto, A., Suzuki, N., Hirano, K., Matsumoto, Y., Morita, A., Sakai, K. and Koyama, H. (2000) Involvement of SAPK/JNK pathway in X-ray-induced rapid cell death of human Tcell leukemia cell line MOLT-4. Cancer Lett. 155: 137-144.
35. Enomoto, A., Suzuki, N., Kang, Y., Hirano, K., Matsumoto, Y., Zhu, J., Morita, A., Hosoi, Y., Sakai, K. and Koyama, H. (2003) Decreased c-Myc expression and its involvement in X-ray-induced apoptotic cell death of human T-cell leukemia cell line MOLT-4. Int. J. Radiat. Biol. 79: 589-600.
36. Nakano, H., Yonekawa, H. and Shinohara, K. (2003) Delayed expression of apoptosis in X-irradiated human leukemic MOLT-4 cells transfected with mutant p53. J. Radiat. Res. (Tokyo) 44: 179-183.
37. Shinohara, K. and Nakano, H. (1993) Interphase death and reproductive death in X-irradiated MOLT-4 cells. Radiat. Res. 135: 197-205.
38. Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H. P., Giardino, I. and Brownlee, M. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 404: 787-790.
39. Nagata, S. (2000) Apoptotic DNA fragmentation. Exp. Cell Res. 256: 12-18.
40. Akagi, Y., Ito, K. and Sawada, S. (1993) Radiation induced apoptosis and necrosis in Molt-4 cells: a study of dose effect relationships and their modification. Int. J. Radiat. Biol. 64: 47-56.
41. Cui, Z. G., Kondo, T., Feril, Jr. L. B., Waki, K., Inanami, O. and Kuwabara, M. (2004) Effects of antioxidants on X-ray- or hyperthermia- induced apoptosis in human lymphoma U937 cells. Apoptosis 9: 757-763.
42. Salganik, R. I. (2001) The benefits and hazards of antioxidants: Controlling apoptosis and other protective mechanisms in cancer patients and the human population. J. Am. Coll. Nutr. 20: 464S-472S.
43. Wahl, G. M. and Carr, A. M. (2001) The evolution of diverse biological responses to DNA damage: insights from yeast and p53. Nature Cell Biol. 3: E277-E286.
44. Crosby, M. E., Oancea, M. and Almasan, A. (2004) p53 binding to target sites is dynamically regulated before and after ionizing radiation-mediated DNA damage. J. Environ. Pathol. Toxicol. Oncol. 23: 67-79.
45. Morita, A., Zhu, J., Suzuki, N., Enomoto, A., Matsumoto, Y., Tomita, M., Suzuki, T., Ohtomo, K. and Hosoi, Y. (2006) Sodium orthovanadate suppresses DNA damage-induced caspase activation and apoptosis by inactivating p53. Cell Death Differ. 341: 499-511.
46. Zheng, T. S., Hunot, S., Kuida, K. and Flavell, R. A. (1999) Caspase knockouts: matters of life and death. Cell Death Differ. 6: 402-411.
47. Nicholson, D. W. (1999) Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6: 1028-1042.
48. Gross, A., McDonnell, J. M. and Korsmeyer, S. J. (1999) BCL-2 family members and the mitochondria in apoptosis. Genes. Dev. 13: 1899-1911.
49. Cheng, E. H., Kirsch, D. G., Clem, R. J., Ravi, R., Kastan, M. B., Bedi, A., Ueno, K. and Hardwick, J. M. (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278: 1966-1968.
50. Rajesh, K. G., Sasaguri, S., Suzuki, R. and Maeda, H. (2003) Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. Am. J. Physiol. Heart Circ. Physiol. 285: H2171-H2178.
51. Song, Y., Li, M., Li, J. C. and Wei, E. Q. (2006) Edaravone protects PC12 cells from ischemic like injury via attenuating the damage to mitochondria. J. Zhejiang Univ. Sci. B 7: 749-756.
52. Mantovani, G., Maccio, A., Madeddu, C., Mura, L., Gramignano, G., Russo, M. R., Murgia, V., Camboni, P., Ferreli, L., Mocci, M. and Massa, E. (2003) The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression. Free Radic. Res. 37: 213-223.
53. McClain, D. E., Kalinich, J. F. and Ramakrishnan, N. (1995) Trolox inhibits apoptosis in irradiated MOLT-4 lymphocytes. FASEB J. 9: 1345-1354.
54. Inanami, O., Takahashi, K. and Kuwabara, M. (1999) Attenuation of caspase-3-dependent apoptosis by Trolox post-treatment of X-irradiated MOLT-4 cells. Int. J. Radiat. Biol. 75: 155-163.
55. Zhang, N., Komine-Kobayashi, M., Tanaka, R., Liu, M., Mizuno, Y. and Urabe, T. (2005) Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain. Stroke. 36: 2220-2225.
56. Yagi, Y., Horinaka, S. and Matsuoka, H. (2005) Edaravone prevented deteriorated cardiac function after myocardial ischemia-reperfusion via inhibiting lipid peroxidation in rat. J. Cardiovasc. Pharmacol. 46: 46-51.
57. Marzatico, F., Porta, C., Moroni, M., Bertorelli, L., Borasio, E., Finotti, N., Pansarasa, O. and Castagna, L. (2000) In vitro antioxidant properties of amifostine (WR-2721, Ethyol). Cancer Chemother. Pharmacol. 45: 172-176.
58. Grdina, D. J., Kataoka, Y., Basic, I. and Perrin, J. (1992) The radioprotector WR-2721 reduces neutron-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in mouse splenocytes when administered prior to or following irradiation. Carcinogenesis 13: 811-814.